This inventor holds 4 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, Sorbonne Université. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 5,383 
4 out of 1,853 
4 out of 263 
Years Active: 2019-2023
Title: Innovator Spotlight: Claire Delehouze
Introduction
Claire Delehouze, an esteemed inventor hailing from La Roche Maurice, France, has made significant contributions to the field of biotechnology with an impressive portfolio of four patents. Her innovative work primarily focuses on developing natural product derivatives aimed at addressing critical cellular processes.
Latest Patents
One of Claire Delehouze's latest patents is titled "Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis." This invention involves a compound represented by a specific general formula (I) and is intended for use as a pharmaceutical drug. The compound targets programmed cell death pathways, notably ferroptosis, oxytosis, and cellular necroptosis. Furthermore, it offers neuroprotective benefits and is designed to prevent or treat disorders linked to these cell death mechanisms. The patent also covers a pharmaceutical composition that includes the compound and its potential applications in organ preservation.
Career Highlights
Throughout her career, Claire Delehouze has been affiliated with prestigious research institutions, including the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her roles in these organizations have provided her with invaluable experience and the resources necessary to advance her research in cellular biology.
Collaborations
Claire has worked alongside prominent colleagues such as Stéphane Bach and Marie-Thérèse Dimanche-Boitrel. Their collaborative efforts have contributed significantly to the advancements in research pertaining to cellular processes and therapeutic interventions.
Conclusion
Claire Delehouze exemplifies the spirit of innovation in the scientific community. Her contributions to the understanding and manipulation of cellular death pathways through her patented work hold the promise of significant advancements in the medical field. As she continues her research, her impact on biotechnology and therapeutic solutions will undoubtedly expand, solidifying her status as a noteworthy inventor.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile